Search results

Found 2,264 pages
AUTHOR: Lynne Taylor

Results per page

10 20 50 100

Sort by

Relevance Date

24 Dec 2009:

US Senate health vote “to make history today”

The US Senate is set to vote today on its $871 billion health reform bill, after a third and final procedural vote yesterday approved a full vote at 7am Washington time this morning. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/us_senate_health_vote_to_make_history_today_984043

26 Jul 2013:

EU probes German pharma aid plan

The European Commission has opened an "in-depth" inquiry into a scheme offering assistance to German pharmaceutical companies which are in financial difficulties. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/eu_probes_german_pharma_aid_plan_1005444

29 May 2012:

New NICE HTA programme includes Velcade, Xarelto

The latest list of medicines to be referred to the National Institute for Health and Clinical Excellence (NICE) for appraisal includes Janssen's Velcade (bortezomib) andBayer HealthCare's Xarelto (rivaroxaban). - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/new_nice_hta_programme_includes_velcade,_xarelto_977248

13 Sep 2011:

SMC OKs Celgene's Vidaza for MDS

The Scottish Medicines Consortium (SMC) has approved the use of Celgene's Vidaza (azacitidine) in patients with advanced myelodysplastic syndromes (MDS). - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/smc_oks_celgenes_vidaza_for_mds_980409

20 Aug 2014:

Biosimilars: US concerns growing

61% of respondents to a survey of physicians who prescribe biologics and biosimilars in Europe believe that if two products share an international nonproprietary name, they are approved for all of the same indications. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/biosimilars_us_concerns_growing_1002353

6 Aug 2008:

EMEA plans to test parallel imports

The European Medicines Agency is planning to include parallel-imported medicines in its annual Sampling and Testing Programme of centrally-authorised products (CAPs). - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/emea_plans_to_test_parallel_imports_988129

4 Apr 2014:

NICE U-turn on Roche's Tarceva

The National Institute for Health and Care Excellence (NICE) has issued revised draft guidance reversing its decision to restrict access to Roche’s Tarceva (erlotinib) in patients with second-line non-small cell lung cancer (NSCLC). - News -

by Lynne Taylor

https://www.pharmatimes.com/news/nice_u-turn_on_roches_tarceva_1001774

14 Oct 2013:

California governor vetoes biosimilars law

California Governor Gerry Brown has vetoed legislation designed to regulate the use of biosimilar drugs in the state. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/california_governor_vetoes_biosimilars_law_1005838

28 Jul 2009:

Philippines forces 50% price cuts for five drugs

The Philippines government has today announced mandatory 50% price cuts for five essential drugs, rejecting their makers’ offers of lower reductions. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/philippines_forces_50_price_cuts_for_five_drugs_983942

17 Aug 2010:

NICE to develop nine new quality standards

The National Institute for Health and Clinical Excellence (NICE) has announced that it will be developing nine new quality standards during 2010/11. - News - PharmaTimes

by Lynne Taylor

https://www.pharmatimes.com/news/nice_to_develop_nine_new_quality_standards_982589